Antenatal Corticosteroids: Short-Term Gains, Long-Term Questions—A Meta-Analysis
Pharmaceuticals · 17.07.2026 · 19 (7) · 1098
DOI: 10.3390/ph19071098 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 17.07.2026. Verfasst von Marharyta Sobczak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunopathology, Division of Biomedical Science, Faculty of Medicine, Medical University of Lodz, 90-752 Lodz, Poland. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.
Abstract (Originalsprache)
Background/Objectives: Antenatal corticosteroids (ACSs) form the basis of prenatal care for women at risk of preterm birth, primarily due to their proven benefits in reducing neonatal mortality and short-term morbidity. However, there are growing concerns about the potential long-term consequences of fetal exposure to ACSs. The aim of the meta-analysis was to assess the relationship between exposure to corticosteroids administered during the prenatal period and long-term effects.
Methods
PubMed, Web of Science, and the Cochrane Central Register of Controlled Trials were searched for studies published up to 28 January 2026. Randomized controlled trials and observational studies reporting long-term outcomes after exposure to ACSs were included. A random effects model was used to calculate effect sizes.
Results
Among the neurological disorders analyzed, our meta-analysis showed an increased risk of 17% of suspected neurocognitive disorder (RR = 1.17; 95% CI [1.13; 1.21]; p < 0.0001, I2 = 10%), 18% of hearing impairment (RR = 1.18; 95% CI [1.13; 1.24]; p < 0.0001, I2 = 41%), 3% of visual impairment (RR = 1.03; 95% CI [1.01; 1.05]; p = 0.0012, I2 = 0%), 25% of autism spectrum disorders (RR = 1.25; 95% CI [1.09; 1.42]; p = 0.001, I2 = 43%) and 25% of any mental or behavioral disorder (RR = 1.25; 95% CI [1.1; 1.43]; p = 0.0008, I2 = 77%). The results of other neurological disorders, as well as other analyzed outcomes, were not statistically significant (p > 0.05).
Conclusions
Although this meta-analysis suggests an increased risk of certain long-term neurological outcomes following prenatal exposure to corticosteroids, these findings should be interpreted with caution in light of the well-documented short-term benefits for newborns and the need for a careful assessment of the benefit–risk ratio and further long-term observational studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunopathology, Division of Biomedical Science, Faculty of Medicine, Medical University of Lodz, 90-752 Lodz, Poland.
- Department of Perinatology, Obstetrics and Gynecology, Polish Mother's Health Center Institute, 93-338 Lodz, Poland.
ORCID-Profile: Marharyta Sobczak, Rafał Pawliczak
Förderung
- Medical University of Lodz
Zitieren
APA
Sobczak, M., Wencka, B., & Pawliczak, R. (2026). Antenatal Corticosteroids: Short-Term Gains, Long-Term Questions—A Meta-Analysis. Pharmaceuticals, 19(7), 1098. https://doi.org/10.3390/ph19071098
Vancouver
Sobczak M, Wencka B, Pawliczak R. Antenatal Corticosteroids: Short-Term Gains, Long-Term Questions—A Meta-Analysis. Pharmaceuticals. 2026;19(7):1098. doi:10.3390/ph19071098
BibTeX
@article{Sobczak2026,
author = {Sobczak, Marharyta and Wencka, Barbara and Pawliczak, Rafał},
title = {Antenatal Corticosteroids: Short-Term Gains, Long-Term Questions—A Meta-Analysis},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {7},
pages = {1098},
doi = {10.3390/ph19071098}
}
EUVIMED